Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...

A massive U.S. study found diabetics on semaglutide (Ozempic’s active ingredient) had up to 70% lower risk of ...

De afslankmiddelen Ozempic en Wegovy worden wereldwijd geprezen om hun effectiviteit. Maar nu deze medicijnen steeds meer ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

Ondanks strenge voorwaarden voor wie het mag krijgen, neemt het gebruik van diabetes­medicijnen als Ozempic fors toe. Het ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

Ondanks strenge voorwaarden voor wie het mag krijgen, neemt het gebruik van diabetesmedicijnen zoals Ozempic fors toe. Ze ...